Microsoft word - hair loss medication in detail
Hair Loss Medication in Detail
Generically named Propecia and also Proscar was developed to treat benign prostatic hyperplasia as a DHT
inhibitor. It was then found to be successful in treating mild to moderate male pattern hair loss on the
vertex (top of head) and anterior mid-scalp area (middle front of head) in men only and should not be
used by women or children
. There is not sufficient evidence that PROPECIA works for receding hairlines
at the temples.
Side Effects were uncommon and did not affect most men
Although rare a small number of men had sexual side effects, with each occurring in less than 2% of men. These included a loss of libido, difficulty in achieving an erection, and a decrease in the amount of semen. These side effects went away in men who stopped taking Finestride. In addition, these side effects decreased to 0.3% of men or less by the fifth year of treatment.
1) Can falsify a PSA test (prostate- specific antigen) used to detect prostate cancer. 2) Allergic reaction symptoms in the form of; rash, hives, swelling of the lips and face, breast
tenderness and enlargement and testicular pain.
Any side effects should be reported to your physician immediately.
It generally takes up to 3 months to see any hair growth. Once you stop taking Propecia the hair loss will once again progress and return to its original state within 12 months.
AVODART reduces serum DHT in a rapid and consistent manner within 1 to 2 weeks. In clinical studies, after 1 and 2 weeks of daily dosing with AVODART 0.5 mg, median serum DHT concentrations were reduced by 85% and 90%, respectively. In patients with BPH treated with AVODART 0.5 mg/day for 2 years, the median decrease in serum DHT was 94% at 1 year and 93% at 2 years.
Physicians should also inform patients that there may be a decrease in ejaculate volume in some men taking AVODART. This effect does not appear to interfere with normal sexual function. In clinical trials, the incidence of impotence and decreased libido, considered by investigators to be drug-related, was 5% with AVODART and 3% with placebo.
Clinical trials showed that it was generally well tolerated. Most side effects were mild or moderate and generally went away while on treatment in both the Avodart and placebo groups.
Drug-related side effects during the first six months were as follows: impotence (4.7 percent vs. 1.7 percent for placebo), decreased libido (3 percent vs. 1.4 percent), breast tenderness and breast enlargement (gynecomastia; 0.5 percent vs. 0.2 percent) and ejaculation disorders (1.4 percent vs. 0.5 percent).
The incidence of most drug-related sexual side effects decreased with duration of treatment. The incidence of drug-related breast tenderness and breast enlargement remained constant over the treatment period. Ejaculate volume may be decreased in some patients with continued treatment. This decrease did not appear to interfere with normal sexual function.
Minoxidil was initially developed to be taken orally for the treatment of high blood pressure. A side effect from taking the medication was hair growth at which time the drug was changed to a topical application. The action of Rogaine is that of a vasodilator which tends to increase circulation in the tissue it is applied to. With hair loss as we know there is a miniaturization of the hair follicles partly due to the action DHT and also due to atrophy of the vascular beds providing nutrition to the follicle. With gradual starving of the follicle the hair produced undergoes miniaturization until ultimately the hair just does not regrow. Rogaine’s action as a vasodilator improves the circulation and nutrition of the hair follicle and thus strengthens existing hair. The resultant hair growth while using Rogaine will reverse once treatment is stopped and one again the hair follicle will undergo miniaturization and will cease to grow.
Use after Transplant – Many transplant surgeons recommend using Rogaine immediately after surgery in order to assist revascularizing the transplanted follicles. This vascularization will also help reduce the amount of shock hair loss from the follicles which exist around the hair transplant site. Recommended usage is up to the physician.
• unwanted facial hair growth (especially in women)
Natural Hair Loss Products
Listed in the table below is a comparison of the four most popular natural hair loss products currently be marketed. These products are manufactured from natural
occurring ingredients and thereby resulting in a reduced possibility of developing any side effects. In fact the majority of these products can be utilized by men and
women and also offer a customer satisfaction guarantee.
Advanced Skin and
dermatologist as a natural alternative to medical management of hair loss without side effect.
acid (GLA), Alpha
Berries, Gotu Kola,
Linolenic acid (ALA),
Linoleic Acid, Oleic
and methionine), Extract, Urtica
are fatty acids
Seed Meal, CJ-11
Azaleic acid, Vitamin
Factor, and Mura
B6 and Zinc
men whose hair is no longer in a growth phase is
possess growth stimulation activity toward hair epithelial cells in vitro and stimulate anagen induction in hair follicles in vivo
inhibits DHT formation. thereby reducing
further loss of hair from the scalp, without causing the sexual side effects of prescription drugs like finasteride (Propecia).
PTT.9004.0001.0033 West Atlas - Drilling Supervisor; Duncan, Craig; Wilson, Chris'Chris Wilson'; Brand, Keith; Loveless, Steven; Glennon, Chris; Higgins, Mathieu Subject: Attachments: 052 SDWA-POB 07 Mar 09.xls; BHI_SLS_Montara H1 ST1_07_070309.xls; SDWA STOP 09-03-07.pdf; 09-3-07 Bulk Report Montara H1 ST1.xls; Montara H1-ST1 DMR# 07.pdf; 09-03-07 DDR 07 Montara H1-ST1.xls Gents, Ple
SYNOLAC 6529 Putty Resin DESCRIPTION: SYNOLAC 6529 is a medium viscosity, highly reactive pre-promoted flexible polyester resin especially designed for automotive and wood filler putties. LIQUID RESIN PROPERTIES (at 25 ° C) These values are listed for a reference guide only. Particular batches may not conform exactly to the numbers listed because storage conditions,